Triple-negative breast cancer in focus: from biology to novel therapeutics. Editorial.
作者信息
Piccart M J
出版信息
Ann Oncol. 2012 Aug;23 Suppl 6:vi5-6. doi: 10.1093/annonc/mds186.
PMID:23012303
Abstract
摘要
相似文献
1
Triple-negative breast cancer in focus: from biology to novel therapeutics. Editorial.
Ann Oncol. 2012 Aug;23 Suppl 6:vi5-6. doi: 10.1093/annonc/mds186.
2
[PARP inhibitors and their role in the therapy of triple-negative metastatic breast cancer].
Przegl Lek. 2012;69(6):265-70.
3
Novel targets for triple-negative breast cancer.
Clin Adv Hematol Oncol. 2011 Sep;9(9):678-80.
4
From the guest editor: Triple-negative breast cancer.
Cancer J. 2010 Jan-Feb;16(1):10-1. doi: 10.1097/PPO.0b013e3181d388ca.
5
New approaches for triple-negative breast cancer.
Oncology (Williston Park). 2012 Oct;26(10):916, 931, 935.
6
Targeted therapy for triple-negative breast cancer: where are we?
Int J Cancer. 2012 Dec 1;131(11):2471-7. doi: 10.1002/ijc.27632. Epub 2012 Jun 7.
7
Promising therapeutic options in triple-negative breast cancer.
J BUON. 2012 Apr-Jun;17(2):209-22.
8
Molecular stratification of triple-negative breast cancers.
Oncologist. 2011;16 Suppl 1:61-70. doi: 10.1634/theoncologist.2011-S1-61.
9
CCR 20th Anniversary Commentary: Triple-Negative Breast Cancer in 2015—Still in the Ballpark.
Clin Cancer Res. 2015 Sep 1;21(17):3813-4. doi: 10.1158/1078-0432.CCR-14-3122.
10
Therapeutic strategies for triple-negative breast cancer.
Cancer J. 2008 Nov-Dec;14(6):343-51. doi: 10.1097/PPO.0b013e31818d839b.
引用本文的文献
1
Association of microRNAs and pathologic response to preoperative chemotherapy in triple negative breast cancer: preliminary report.
Mol Biol Rep. 2014 May;41(5):2851-7. doi: 10.1007/s11033-014-3140-7. Epub 2014 Jan 29.
Zotero 插件